Meeting
2020 ASCO Virtual Scientific Program
Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).
Authors
Keunchil Park
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
Keunchil Park , Thomas John , Sang-We Kim , Jong Seok Lee , Catherine A. Shu , Dong-Wan Kim , Santiago Viteri Ramirez , Alexander I. Spira , Joshua K. Sabari , Ji-Youn Han , Jose Manuel Trigo , Chee Khoon Lee , Ki Hyeong Lee , Nicolas Girard , Patricia A Lorenzini , John Xie , Amy Roshak , Meena Thayu , Roland Elmar Knoblauch , Byoung Chul Cho
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02609776
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9512)
DOI
10.1200/JCO.2020.38.15_suppl.9512
Abstract #
9512
Poster Bd #
278
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Risk factors for venous thromboembolism (VTE) among patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) receiving amivantamab plus lazertinib versus either agent alone.
First Author: Nicolas Girard
Poster
2023 ASCO Annual Meeting
Emerging phase 1 data of BLU-451 in advanced NSCLC with EGFR exon 20 insertions.
First Author: Danny Nguyen
Poster
2021 ASCO Annual Meeting
Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy.
First Author: Anna Rachel Minchom
Poster
2024 ASCO Annual Meeting
Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-MET exon 14 skipping mutations (METex14).
First Author: Mariana da Rocha Almeida Brandao